Last update 15 Feb 2025

Annamycin liposomal(Moleculin Biotech)

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms-
Target
Top II
Mechanism
Top II inhibitors(Topoisomerase II inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic DiseasesOther Diseases
Active Indication
Acute Myeloid LeukemiaSoft Tissue Sarcoma
Inactive Indication-
Originator Organization
Moleculin Biotech, Inc.Moleculin Biotech, Inc.
Active Organization
Moleculin Biotech, Inc.Moleculin Biotech, Inc.
Inactive Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

7
Clinical Trials associated with Annamycin liposomal(Moleculin Biotech)
NCT06788756
/ Not yet recruitingPhase 2/3
A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination with Cytarabine Injection Versus Placebo in Combination with Cytarabine Injection As Second Line Therapy for Remission Induction in Adult Subjects with Refractory/Relapsed Acute Myeloid Leukemia
NCT05319587
/ Active, not recruitingPhase 1/2
Phase 1/2 Study of Liposomal Annamycin in Combination with Cytarabine for the Treatment of Subjects with Acute Myeloid Leukemia (AML)
EUCTR2021-003762-13-PL
/ Not yet recruitingPhase 1/2IIT
PHASE 1B/2 STUDY OF LIPOSOMAL ANNAMYCIN (L-ANNAMYCIN) IN PATIENTS WITH PREVIOUSLY TREATED SOFT-TISSUE SARCOMAS WITH METASTASES (ANNA-SARC) - ANNA-SARC
100 Clinical Results associated with Annamycin liposomal(Moleculin Biotech)
Login to view more data
100 Translational Medicine associated with Annamycin liposomal(Moleculin Biotech)
Login to view more data
100 Patents (Medical) associated with Annamycin liposomal(Moleculin Biotech)
Login to view more data
100 Deals associated with Annamycin liposomal(Moleculin Biotech)
Login to view more data

External Link

KEGGWikiATCDrug Bank
-Annamycin liposomal(Moleculin Biotech)-
DB06420

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 3-
Moleculin Biotech, Inc.Moleculin Biotech, Inc.
01 Jan 2025
Soft Tissue SarcomaPhase 2
US
Moleculin Biotech, Inc.Moleculin Biotech, Inc.
05 Jun 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free